Structure-Modifying Capacity of Anti-Tumour Necrosis Factor- Therapy in Ankylosing Spondylitis

By Filip De Keyser   Baeten Dominique   Filip Van den Bosch   Kruithof Elli   Verbruggen Gust   Mielants Herman   Veys Eric  

Drugs, Vol. 64, Iss. 24, 2004-01 ,pp. : 2793-2811

Adis International

Access to resources Recommend Favorite

Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy

By Barygina V.V.  

Redox Report, Vol. 18, Iss. 3, 2013-05 ,pp. : 100-106

Maney Publishing

Access to resources Recommend Favorite

TNF-α -857 and -1031 polymorphisms predict good therapeutic response to TNF-α blockers in Chinese Han patients with ankylosing spondylitis

By Tong Qiang   Zhao Dong-Bao   Bajracharya Punam   Xu Xia   Kong Rui-Na   Zhang Ju   Dai Sheng-Ming   Cai Qing  

Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. : 1459-1467

Future Medicine

Access to resources Recommend Favorite

Etanercept: TNF antagonist effective in ankylosing spondylitis

By  

Inpharma, Vol. 1, Iss. 1402, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Compliance with NICE guidance on the use of anti-TNFα agents in ankylosing spondylitis: an East and West Midlands regional audit

By Rees Frances   Peffers Gillian   Bell Carolyn   Obrenovic Karen   Sandhu Ravinder   Packham Jonathan   Erb Nicola  

Clinical Medicine, Vol. 12, Iss. 4, 2012-08 ,pp. : 324-327

Royal College Of Physicians

Access to resources Recommend Favorite